All Mergers and acquisitions articles
View all stories with this category.
-
BusinessUS trade regulator sues to block Amgen–Horizon merger
Federal Trade Commission has concerns that union will allow Amgen to stifle potential competition for Horizon’s drugs
-
Business
Pfizer to buy cancer biotech Seagen for $43 billion
Antibody-drug conjugate specialist will fill Pfizer’s cancer pipeline
-
Business
Chemicals industry roundup 2022
Russia’s invation of Ukraine mounted further pressure onto already strained supply chains
-
Business
Pharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
Business
Haleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
-
Business
DSM and Firmenich to merge
Flavour and fragrance-focused Firmenich complements DSM’s transition away from traditional chemicals
-
Business
Pharmaceuticals roundup 2021
It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry
-
Business
Morphosys agrees to buy cancer epigenetics specialist Constellation
$1.7bn deal will be funded by selling rights to royalties on existing drugs
-
Business
Shell to sell US refinery stake to Mexican state-owned petroleum company
Pemex will take full control of Deer Park refinery, as Mexico’s president moves to gain energy independence
-
Business
Government clears merger of SinoChem and ChemChina
China’s chemicals giants will unite under a state-run holding company
-
Business
Biggest venture yet of any pharma company into cannabis
Jazz Pharmaceuticals buys cannabinoid therapeutic firm for $7.2 billion, inheriting first plant-derived cannabinoid medicine ever approved by FDA
-
Business
Chemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
Business
Pharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
Business
AstraZeneca to buy rare disease drugmaker Alexion in $39bn deal
Transaction would be the largest in AstraZeneca’s history
-
Business
Ineos to buy BP petrochemicals businesses for $5bn
Deal covers 14 acetyls and aromatics manufacturing plants and 10 joint ventures
-
Business
Bayer commits over $10bn to resolve legacy Monsanto lawsuits
Agreement settles about 75% of Roundup-related cases and resolves PCB and dicamba litigation
-
Business
Pharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
Business
Chemicals industry roundup 2019
Focus turns to sustainability amid rising economic pressures and political uncertainty
-
Business
Pfizer’s Upjohn to merge with Mylan
Deal combines Pfizer’s off-patent drug portfolio with Mylan’s generics
-
Business
US judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
